Symptoms and Signs Clinical Trial
— LOCONOZ2Official title:
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air for 6.6 Hours With Moderate Exercise in Healthy Young Adults
Purpose: The primary purpose of this study is to measure pulmonary function, symptoms, and pulmonary inflammatory responses in healthy young adults during and immediately after exposure to a low concentration of ozone (0.070 ppm) or clean air for 6.6 hours while undergoing moderate intermittent exercise. This concentration is the current EPA NAAQS standard for ozone.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | February 1, 2025 |
Est. primary completion date | February 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: 1. Healthy men and women between 18 and 35 years of age. 2. Physical conditions allowing sustained moderate exercise for 6.6 hours. 3. Normal lung function (NHANES III): 1. FVC > 80 % of that predicted for gender, ethnicity, age and height. 2. FEV1 > 80 % of that predicted for gender, ethnicity, age and height. 3. FEV1/FVC ratio > 80 % of predicted values 4. Oxygen saturation > 94 %. 5. Total symptom Score no greater than 20 (out of a possible 60-see accompanying score sheet) with a value no greater than 3 for any one score. No more than one score may be equal to 3. Exclusion Criteria: 1. Individuals with a diagnosis of COVID-19 and/or hospitalized for COVID-19. 2. Individuals who are not "up to date," [meaning a person has received all recommended COVID-19 vaccines, including any booster dose(s) when eligible with their COVID vaccines as defined by the CDC.] 3. A history of acute and chronic cardiovascular disease, chronic respiratory disease, diabetes,rheumatologic diseases, immunodeficiency state. 4. An acute respiratory illness within 4 weeks. 5. Subjects who are asthmatic or have a history of asthma. 6. Allergic to chemical vapors or gases. 7. Any allergic symptoms during the time of participation in the study 8. Female subjects who are currently pregnant, attempting to become pregnant or breastfeeding 9. Subjects currently taking mega doses of vitamins and supplements, homeopathic/naturopathic medicines or medications which may impact the results of the ozone challenge or interfere with any other medications potentially used in the study (to include systemic steroids and beta blockers). Medications not specifically mentioned here may be reviewed by the investigators prior to a subject's inclusion in the study. 10. Current and past smokers within 2 years, or subjects with a smoking history of at least a pack of cigarettes a day for more than 10 years over your lifetime. This includes vaping, hookah,and e-cigarettes. 11. Uncontrolled hypertension (> 140 systolic, > 90 diastolic). Blood pressure readings equal to or greater that 140 Systolic and equal to or greater that 90 diastolic. 12. Subjects who do not understand or speak English 13. Unspecified illnesses, which in the judgment of the investigator might increase the risk associated with ozone inhalation challenge or exercise, will be a basis for exclusion. Temporary exclusion criteria: 1. Individuals who have had an acute respiratory illness within 4 weeks. 2. Individuals who have active allergies. 3. Individuals that have engaged in strenuous exercise within 24 hours of any study visit. 4. Individuals unable to avoid drinking alcohol for 24 hours prior to all study visits. 5. Individuals who have been exposed to smoke and fumes for 24 hours before all visits. 6. Individuals that have used an ozone-based home air purifier for 24 hours before all visits. 7. Individuals that have eaten or drank anything for 2 hours prior to the sputum training/screening day visit. 8. Individuals should avoid caffeine for 12 hours prior to all study visits. 9. Individuals should refrain from all over the counter anti-inflammatory agents including those for allergies, and anti-inflammatory drugs or antioxidants for a period of one week prior to the train and to the exposure. 10. Individuals that have been exposed to or have consumed any agent or have undertaken any activity within 24 hours of any study visit that the investigators believe may compromise the results of the study. - |
Country | Name | City | State |
---|---|---|---|
United States | EPA Human Studies Facility | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Martin W. Case | University of North Carolina |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | FVC | forced vital capacity | measured (pre) before starting 6.6 hours of exercise | |
Primary | Change in FVC | change in forced vital capacity | change measured (post) immediately after 6.6 hours of exercise | |
Primary | FEV1 | forced expiratory volume in 1 second | measured (pre) before starting 6.6 hours of exercise | |
Primary | Change in FEV1 | change in forced expiratory volume in 1 second | change measured (post) immediately after 6.6 hours of exercise | |
Secondary | % neutrophils collected by induced sputum | Subjects will breathe a hypertonic saline solution from an ultrasonic nebulizer through a mouthpiece at saline concentrations of 3%, 4%, and 5%. After each inhalation period subjects be asked to cough up the expectorate in a sterile cup for analysis of neutrophil cells influx | baseline: training/qualification day | |
Secondary | change in % neutrophils collected by induced sputum | Subjects will breathe a hypertonic saline solution from an ultrasonic nebulizer through a mouthpiece at saline concentrations of 3%, 4%, and 5%. After each inhalation period subjects be asked to cough up the expectorate in a sterile cup for analysis/quantitation of neutrophil cells influx | 18 hours post exposure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04892004 -
Symptom Recognition Improves Self-care in Patients With Heart Failure.
|
N/A | |
Recruiting |
NCT06446999 -
Yoga-Based Breathing Exercise, Colorectal Cancer Surgery
|
N/A | |
Not yet recruiting |
NCT05505188 -
Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer
|
N/A | |
Completed |
NCT04864600 -
CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles
|
N/A | |
Completed |
NCT03336177 -
Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
|
||
Completed |
NCT06395025 -
Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group
|
N/A | |
Completed |
NCT04292665 -
Effects of Classical Massage and Benson Relaxation Exercise on Heart Failure Patients
|
N/A | |
Recruiting |
NCT05681975 -
Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
|
||
Completed |
NCT04169919 -
Modified Treatment for Epidemic Keratoconjunctivitis (EKC)
|
N/A | |
Recruiting |
NCT06436651 -
Digital Storytelling in Symptom Management Pediatric Oncology
|
N/A | |
Recruiting |
NCT04940780 -
Integrative Oncology for Patient Symptoms
|
N/A | |
Not yet recruiting |
NCT05837988 -
Construction of Symptom Network in Maintenance Hemodialysis Patients
|
||
Recruiting |
NCT05092568 -
Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
|
||
Recruiting |
NCT03968718 -
PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice
|
N/A | |
Completed |
NCT05556707 -
Symptom Clusters and Risk Factors of COVID-19 Patients
|
||
Completed |
NCT06153680 -
Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return
|
N/A | |
Completed |
NCT04873349 -
Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients
|
N/A | |
Recruiting |
NCT06136221 -
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
|
N/A | |
Recruiting |
NCT05827406 -
A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP)
|
||
Completed |
NCT06215339 -
Diet Therapy in Hemodialysis Patients
|
N/A |